Vanda Pharmaceuticals Statistics
Total Valuation
VNDA has a market cap or net worth of $439.09 million. The enterprise value is $182.31 million.
Important Dates
The last earnings date was Wednesday, February 11, 2026, after market close.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VNDA has 59.10 million shares outstanding. The number of shares has increased by 1.34% in one year.
| Current Share Class | 59.10M |
| Shares Outstanding | 59.10M |
| Shares Change (YoY) | +1.34% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 5.14% |
| Owned by Institutions (%) | 70.94% |
| Float | 52.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.03 |
| Forward PS | 1.67 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 2.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.39 |
| Quick Ratio | 2.19 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -50.93% and return on invested capital (ROIC) is -119.23%.
| Return on Equity (ROE) | -50.93% |
| Return on Assets (ROA) | -16.50% |
| Return on Invested Capital (ROIC) | -119.23% |
| Return on Capital Employed (ROCE) | -43.97% |
| Weighted Average Cost of Capital (WACC) | 7.34% |
| Revenue Per Employee | $587,242 |
| Profits Per Employee | -$599,114 |
| Employee Count | 368 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 7.29 |
Taxes
In the past 12 months, VNDA has paid $81.83 million in taxes.
| Income Tax | 81.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +60.82% in the last 52 weeks. The beta is 0.58, so VNDA's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +60.82% |
| 50-Day Moving Average | 7.16 |
| 200-Day Moving Average | 5.29 |
| Relative Strength Index (RSI) | 48.88 |
| Average Volume (20 Days) | 889,080 |
Short Selling Information
The latest short interest is 2.88 million, so 4.87% of the outstanding shares have been sold short.
| Short Interest | 2.88M |
| Short Previous Month | 2.34M |
| Short % of Shares Out | 4.87% |
| Short % of Float | 5.48% |
| Short Ratio (days to cover) | 1.28 |
Income Statement
In the last 12 months, VNDA had revenue of $216.11 million and -$220.47 million in losses. Loss per share was -$3.74.
| Revenue | 216.11M |
| Gross Profit | 203.06M |
| Operating Income | -151.17M |
| Pretax Income | -138.65M |
| Net Income | -220.47M |
| EBITDA | -143.10M |
| EBIT | -151.17M |
| Loss Per Share | -$3.74 |
Full Income StatementBalance Sheet
The company has $263.85 million in cash and $7.07 million in debt, with a net cash position of $256.78 million or $4.35 per share.
| Cash & Cash Equivalents | 263.85M |
| Total Debt | 7.07M |
| Net Cash | 256.78M |
| Net Cash Per Share | $4.35 |
| Equity (Book Value) | 327.19M |
| Book Value Per Share | 5.54 |
| Working Capital | 202.10M |
Full Balance SheetMargins
Gross margin is 93.96%, with operating and profit margins of -69.95% and -102.02%.
| Gross Margin | 93.96% |
| Operating Margin | -69.95% |
| Pretax Margin | -64.16% |
| Profit Margin | -102.02% |
| EBITDA Margin | -66.22% |
| EBIT Margin | -69.95% |
| FCF Margin | n/a |
Dividends & Yields
VNDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.34% |
| Shareholder Yield | -1.34% |
| Earnings Yield | -50.21% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for VNDA is $13.63, which is 83.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.63 |
| Price Target Difference | 83.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
